- Staat
- AZ
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 21.04.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Cardiovascular insufficiency
Dizziness
Dyspnoea
Oxygen saturation decreased
Respiratory distress
Throat tightness
Urticaria
Symptomtext
At 1525, medical emergency response system activated for a patient that was having an anaphylactic response to one of the vaccines that she had received. The patient had hives on her lower legs, she was struggling to catch her breath, felt her throat was closing, and was dizzy. The patient was given epinephrine 0.3mg at 1526 in her left vastus lateralis. Oxygen was administered to the patient as her O2 level was slowly dropping and she appeared in respiratory distress. BP at that time was 145/90, O2 97%, pulse 84. Vitals were monitored at the following times: 15:30: 127/72, pulse 66, 98% 2L 15:33: 120 78,84, 99% RA 15:42: 128/ 87 The patient's PCP was notified of the event. She recommended the patient seek care at the ER due to possible rebound from the epi. The patient agreed to us calling EMS to transport her. 1549: 135/87, pulse 70, O2 99% RA Fire department arrived: 1549 EMS arrived: 1605 Nursing Assessment: Airway: Open Breathing: Labored Circulation: Pulse present Mentation: Alert Skin: Hives She was transported to the emergency department via ambulance at 1605.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Omalizumab, Dexamethasone, Dates, Latex, Milk, Peanut
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 21.10.2022
- Impfdatum
- 20.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bursitis
Injected limb mobility decreased
Pain in extremity
Symptomtext
Customer stated pain and lack of mobility in right arm. She went to doctor and he told her that the bursa was inflamed. she was prescribed tramadol and medrol dosepak for the pain and inflammation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 19.05.2022
- Impfdatum
- 12.05.2022
- Beginn
- 19.05.2022
- Tage bis Beginn
- 7,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injected limb mobility decreased
Loss of personal independence in daily activities
Vaccination site bruising
Vaccination site pruritus
Vaccination site swelling
Symptomtext
Patient is here regarding bruising from IZ from last week. Stated unsure if its from Pneumo or Tdap vaccine. Patient stated that vaccine bruising gets itchy, starts swelling, & affects daily routine because she is unable to move her arm around. Prescribed ibuprofen 600 mg tablet
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Vitamin D deficiency ICD-9-CM: 268.9 ICD-10: E55.9 Relevant Orders 25 HYDROXY INCLUDES FRACTIONS IF PERFORMED Hypothyroid ICD-9: 244.9 ICD-10: E03.9 Current Assessment & Plan -Recent ER visit for anxiety. EKG indicated a heart rate of 105 with flattened T waves. Repeat EKG today is normal sinus rhythm without ST abnormalities. -Last TSH level 5.59 ( 6 months ago) -Currently taking levothyroxine 50 mcg/day. Patient states she has not been taking extra doses. -Repeat TSH History of vitamin D deficiency ICD-9: V12.1 ICD-10: Z86.39 Current Assessment & Plan Check level History of abnormal electrocardiogram ICD-9: V12.59 ICD-10: Z86.79 Current Assessment & Plan Recent ER visit for anxiety. EKG at that time showed sinus tach, rate 105 with flattened T waves. Repeat EKG today normal sinus rhythm without ST or T wave abnormalities.
- Vorgeschichte
- Vitamin D deficiency ICD-9: 268.9 ICD-10: E55.9 Relevant Orders 25 HYDROXY INCLUDES FRACTIONS IF PERFORMED Hypothyroid ICD-9: 244.9 ICD-10: E03.9 Current Assessment & Plan -Recent ER visit for anxiety. EKG indicated a heart rate of 105 with flattened T waves. Repeat EKG today is normal sinus rhythm without ST abnormalities. -Last TSH level 5.59 ( 6 months ago) -Currently taking levothyroxine 50 mcg/day. Patient states she has not been taking extra doses. -Repeat TSH History of vitamin D deficiency ICD-9: V12.1 ICD-10: Z86.39 Current Assessment & Plan Check level History of abnormal electrocardiogram ICD-9: V12.59 ICD-10: Z86.79 Current Assessment & Plan Recent ER visit for anxiety. EKG at that time showed sinus tach, rate 105 with flattened T waves. Repeat EKG today normal sinus rhythm without ST or T wave abnormalities.
- Andere Medikamente
- fluticasone propionate (FLONASE) 50 mcg/actuation nasal spray azelastine (OPTIVAR) 0.05 % ophthalmic solution 6 mL ergocalciferol, vitamin D2, (VITAMIN D2) 1,250 mcg (50,000 unit) levothyroxine (EUTHYROX) 50 mcg tablet sertraline (ZOLOFT)
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Injected limb mobility decreased
Pain in extremity
Product administered at inappropriate site
Symptomtext
No Help from Dr sore right arm so bad can't move Hand the first day. Arm still sore 1 week later
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Omega 3 Fish oil, Colace, multiple Vitamin Flax seed Fiber
- Allergien
- Niacin
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Injected limb mobility decreased
Pain in extremity
Product administered at inappropriate site
Symptomtext
No Help from Dr sore right arm so bad can't move Hand the first day. Arm still sore 1 week later
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Omega 3 Fish oil, Colace, multiple Vitamin Flax seed Fiber
- Allergien
- Niacin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 12.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 05.05.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arrhythmia
Asthenia
Blood test
Chest X-ray
Chills
Computerised tomogram head
Echocardiogram
Electrocardiogram
Immunisation reaction
Myalgia
Pyrexia
Symptomtext
Two days after received pneumovax and shingrix, patient developed generalized weakness associated with fever, chills, myalgias, and arrhythmia. He was admitted to Medical Center and discharged two days later. He is now doing ok. He was diagnosed with vaccine adverse reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arrhythmia
- Hospital-Tage
- 2,0
- Labordaten
- Chest X-ray 05/05/2022 CT Head 05/06/2022 Echocardiogram 05/06/2022 EKG 05/07/2022 Blood tests 05/05/2022, 05/06/2022, 05/07/2022
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- - Schwannoma - Acoustic Neuroma - Hearing loss right ear
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 28.04.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pruritus
Mobility decreased
Pain in extremity
Symptomtext
Pt. states that she received the pneumovax and shingrix in the L delt. Later that day she started developing large red blotches that ran from upper left arm to just above the elbow. She said her arm was extremely sore. The blotches lasted for about 5 days. Itching near shoulder. The day after the vaccines were administered, pt. vomited all day, and spent most of the day in bed. Pt. says she feels fine today ,(4/28).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- asthma, mild emphysema, depression, allergic rhinitis, rheumatoid arthritis, carpal tunnel, gall stones.
- Andere Medikamente
- trazodone, tizanidine, vitamin D, gabapentin, acetaminophen, tramadol, proventil, breo ellipta, incruse ellipta, citalopram, omeprazole, montelukast, lorazepam, meloxicam, prednisone, allergy shots, vitamin C, Vitamin B-50, Spiriva, allergy
- Allergien
- Flu vaccine, (anaphylaxis), cyclobenzaprine, methotrexate, codeine, sulfa, narco
- Vorherige Impfungen
- Pt. reports anaphylaxis after a flu shot.
- Staat
- NY
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 20.11.2022
- Impfdatum
- 17.11.2022
- Beginn
- 17.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain upper
Diarrhoea
Fatigue
Inflammation
Injection site pain
Lymph node pain
Muscle spasms
Vomiting
Symptomtext
Pain at injection site lasted over 48 hours. Hand on same arm had some inflammation, which started 36 hours after injection and is diminishing at 72 hours. Painful lymph node behind jaw on same side of body. Vomited 32 hours after injection, then had stomach pain and cramps with loose stool for several hours. Fatigue started after 24 hours and is continuing at 72 hours after injection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- osteoarthritis (knees)
- Andere Medikamente
- Rosuvastatin Hydrochlorothiazide
- Allergien
- none known
- Vorherige Impfungen
- 08/15/2018 (62 years old), shingles, Shingrix (2nd dose). Low grade fever, aches, fatigue
- Staat
- AR
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 14.11.2022
- Impfdatum
- 09.11.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site pruritus
Injection site reaction
Injection site vesicles
Symptomtext
Patient had an injection reaction. A day after the reaction she had welpy bumps around the injection that were itchy. The next day they were not itchy, just sore.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- -
- Geschlecht
- M
- Eingang
- 06.10.2022
- Impfdatum
- 01.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Symptomtext
Patient came to pharmacy on 10/4 after receiving vaccine to complain of severe arm pain with a picture of supposed location of immunization taken by patient. I had a conversation with him about the staff member who administered the vaccine and asked about his present symptoms. Reassured patient that staff member would immediately be re-trained and patient asked to be updated after.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 19.09.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site cellulitis
Injection site discolouration
Injection site erythema
Injection site swelling
Symptomtext
Left deltoid became swollen and red, for a few days, now improving but still slightly red and yellow. According to pt, looked similar to cellulitis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- post stem cell transplant in 2018 for Hemophagocytic Lymphohistiocytosis, avascular necrosis
- Vorgeschichte
- HLH/MAS
- Andere Medikamente
- Prolia, Tums, Vitamin D, Estradiol, Toprol XL, Prednisone, Ursodiol, Valcyclovir
- Allergien
- Vancomycin, adhesive tape
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 09.09.2022
- Impfdatum
- 12.08.2022
- Beginn
- 13.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Injection site discolouration
Injection site swelling
Pyrexia
Symptomtext
Patient called and stated that the 4 hours after receiving the vaccine, she got localized swelling at the site of the injection and mild fever. The swelling area got larger and became little discolored and bluish. She took Acetaminophen 500 mg and went to urgent care next day (Aug 13th). The swelling started to go down on Aug 13th and was resolved the same day. She did not take any medication for swelling.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discolouration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hypertension
- Andere Medikamente
- Lisinopril, HCTZ
- Allergien
- codeine
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 20.07.2022
- Impfdatum
- 18.07.2022
- Beginn
- 18.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Feeling hot
Joint swelling
Peripheral swelling
Symptomtext
swollen arm down to elbow, hot to touch, temperature of 101 and chills
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- hypertension
- Andere Medikamente
- meloxicam 15 cipro 500 lisinopril/hctz 10/12.5
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 28.06.2022
- Impfdatum
- 26.06.2022
- Beginn
- 27.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Injection site erythema
Injection site swelling
Peripheral swelling
Symptomtext
After vaccination, next morning patient noticed the vaccine arm ( right upper arm) swollen and red. No itching or pain on the site. Patient came to the clinic to show the arm after two days, vaccine site no swelling, redness or any signs of infection. But swelling and redness noticed around the right elbow and patient reports the swelling is much better and the whole arm was swollen before
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None this time other than ice compress and elevated the arm and will start antibiotics if any sign of infection and ultrasound if swelling persist
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hyperlipidemia , tachycardia
- Andere Medikamente
- Simvastatin, Propafenone, Vitamin D3, calcium
- Allergien
- Sulfa drugs
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 15.06.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Myalgia
Symptomtext
Severe deltoid pain x 4days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Inflammation
Neck pain
Pain
X-ray
Symptomtext
pain in shoulder up to neck in area that would support Bursal injection and inflammation with pain on any shoulder motion. he started Aleve BID -- we changed that to Medrol dose pak and gave him intraBursal injection of depo-medrol and lidocaine on 5/20/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- exam and xray in office on 5/20/2022
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hypothyroid, Low testosterone, Hypertension, Chronic diarrhea from Total Colectomy from Colonic ischemia unknown cause.
- Andere Medikamente
- Levothyroxine, Liothyronine, Testosterone, Amlodipine, Lomotil, Cholestyramine, Bcomplex, Vitamin C, MVi, Dhea
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 03.05.2022
- Impfdatum
- 23.04.2022
- Beginn
- 23.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: PATIENT CAME INTO THE PHARMACY AFTER SYMPTOMS HAD RESOLVED. HE CLAIMS HIS ARM SWELLED FROM THE ELBOW TO THE SHOULDER SO BADLY THAT HIS SKIN WAS STRETCHED. IT WAS VERY TENDER, RED AND PAINFUL. WHEN I ASKED HIM IF HE SOUGHT MEDICAL ATTENTION HE SAID NO. HE FIGURED IT WOULD JUST GO AWAY BY ITSELF . (WHICH IT DID)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 09.03.2022
- Beginn
- 10.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site discolouration
Injection site swelling
Injection site warmth
Symptomtext
Swelling and warm at the site of injection with some yellowish discoloration
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discolouration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, MRI, TIA, ANXIETY, PULMONARY HYPERTENSION
- Andere Medikamente
- Tylenol; amlodipine; apixaban; atenolol; atorvastatin; azelastine; tums; cetirizine; vit D3; vit B12; Duloxetine; Famotidine; Myrbetriq; Singulair; Protonix; aspercreme
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 19.04.2022
- Beginn
- 20.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Headache
Injection site bruising
Injection site erythema
Injection site induration
Injection site infection
Injection site pain
Myalgia
Sleep disorder
Symptomtext
Starting day 2, significant injection site pain and redness. Bad headache, intense muscle pains and low back pain that kept me awake. This went on for almost 3 days. Redness in arm spread to an area approx 6 inches in diameter with a hard center. On Day 3, the injection site itself had a bit of blue I thought was a delayed bruise. The hard center was ~2 inches in diameter and very tender to touch. On Day 4 the redness went down a bit but the center started showing signs of clear infection. A circle ~1/2 inch of blue/white. Day 5 went to urgent care and was prescribed docycycline hyclate 100mg 10 day course. The redness and swelling are decreasing, ~3 inches in diameter, hard core ~2in diameter. Still signs of infection in the middle. Applying hot compresses 2x/day since Day 3.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Long COVID with cardiac and pulmonary symptoms.
- Vorgeschichte
- Chronic pelvic and low back pain, mild asthma.
- Andere Medikamente
- Progesterone and estrogen (HRT), Vicodin, Belbuca, Metoprolol succinate
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 22.04.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pain
Injection site swelling
Pain in extremity
Peripheral swelling
Symptomtext
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: arm swelling and soreness-Severe
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 18.04.2022
- Impfdatum
- 14.04.2022
- Beginn
- 14.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Vertigo
Symptomtext
dizziness, vertigo
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- intermittent asthma osteoarthritis of bilateral knee seasonal allergic rhinitis
- Andere Medikamente
- Diclofenac sodium(voltaren) 1% top gel Fluticasone(Flonase) nasal spray
- Allergien
- Aspirin, cotrimazole hydrocodone
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 14.04.2022
- Impfdatum
- 11.04.2022
- Beginn
- 12.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Axillary pain
Erythema
Oedema peripheral
Symptomtext
Redness and swelling in the armpit. Patient noted some pain and swelling in the armpit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Dyslipidemia Hypothyroid
- Andere Medikamente
- Prescribed meds
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 12.04.2022
- Impfdatum
- 01.04.2022
- Beginn
- 03.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pruritus
Rash
Symptomtext
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 04.04.2022
- Impfdatum
- 17.03.2022
- Beginn
- 17.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Decreased appetite
Peripheral swelling
Pyrexia
Rash pruritic
Skin warm
Tenderness
Symptomtext
She stated she developed a 101 fever, low appetite, her arm swelled up down to her write, had itchy rash, arm is warm and tender to touch. Reaction subsided after 4 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN, GERD,diseas of thyroid, lactose intolerance, PVC,IBS,Sciatica
- Andere Medikamente
- see attached
- Allergien
- verapamil, vicodin,motrin,myscostatin, tegretol, sulfa
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 01.04.2022
- Impfdatum
- 16.03.2022
- Beginn
- 17.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Flushing
Herpes zoster
Pain
Pyrexia
Rash
Symptomtext
the night of the vaccine patient had some flushing and subjective fevers however felt okay. Following day in evening he developed Burning pain in his right shoulder that "felt like even his hair was on fire". The following morning he developed a rash which I diagnosed as shingles.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Barrett's esophagus without dysplasia, OSA, aneurysm of anterior communicating artery, TIA
- Andere Medikamente
- Clopidogrel, Voltaren gel, Neurontin, Crestor, Viagra, Flomax, daily aspirin
- Allergien
- nkda
- Vorherige Impfungen
- Patient believes he developed widespread urticarial rash after Tdap vaccine over 50 years ago. He is not sure the exact nature
- Staat
- WA
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 30.03.2022
- Impfdatum
- 23.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood lactic acid
Blood pressure decreased
Blood test normal
Chest X-ray
Dizziness
Feeling abnormal
Full blood count
Headache
Hyperhidrosis
Influenza virus test negative
Injection site cellulitis
Injection site erythema
Injection site induration
Injection site pain
Injection site warmth
Lethargy
Lipase
Liver function test
Symptomtext
Patient received vaccine in primary care clinic on 3/23/2022 around 10:00am at routine wellness exam. Patient sent at 8:35am on 3/25/2022 correspondence stating, "Hi Dr. I just wanted to check to make sure the side effects I started experience on Thursday morning after getting the Pneumonia booster on Wednesday are normal. I started feeling very lethargic and had sharp pain at the site of the injection starting Thursday morning, and by the evening I very achey all over, running a fever and experience bad headaches. Those systems persisted through the night and I?ve woken up this morning (Friday) feeling just as bad. Is this a normal reaction or should I be concerned? If normal, how long does it usually last? Thank you" Patient was informed by Dr. at 11:32am on 3/25/2022: "Hi - not normal but it can happen rarely. It would be expected to last just a day or two. It might be worth getting a covid test just to be sure. Otherwise tylenol or ibuprofen as needed. You can apply heat to the injection site. Let us know if not resolving in next couple of days. " Over the weekend when the electronic messaging is not monitored and patients are advised to call for emergent issues, at 10:59pm on 3/26/22 patient wrote: "Hi Dr., Reaching out again as things have not improved and got much worse yesterday. My temp was around 101 all day yesterday until around 6pm, when it spiked to 104 and I got extremely dizzy. At that point I went to the ER. When they were doing intake, my blood pressure dropped to 60/20. They got me laying flat and on an IV quickly, where my blood pressure returned to around 90/57. I was there from 6:30pm to 10pm, during which they gave me 2 liters of IV fluid, ran blood test, tested for Covid and flu. Covid and flu test came back negative, and all blood test were normal. Up through that point, my symptoms had still just been constant headaches, strong pain at the site of injection and persistent high fever. Because the injection site didn?t show any other signs of reaction, the doctor said it must be something viral and told me to just alternate ibuprofen and Tylenol. When I left hospital, temp was steady around 98 and blood pressure was 100/60. After I got home, weirdly injection site started developing faint redness. I took Tylenol and slept most of the night with some on and off fever sweats. Today I have 1000mg Tylenol every 5-6 hrs, and 600mg ibuprofen twice, 8 hrs apart. My temp has been in the high 99s most of the day, with a spike to 100.8 at 5pm and then another spike to 101 at 10 pm. Both times occurred around 5 hours after Tylenol as it seemed to wear off. Headaches have also persisted. Along with that, the red patch on my arm has grown considerably in size, gotten stiff to the touch and is constantly extremely hot to the touch. Even with all the pain meds, I?ve had a throbbing and sometimes stinging pain. With how my arm has developed, it seems even more likely it?s a reaction to the vaccine and continues to get worse after 3 nights and 2 full days of headache and fever. Do I need an antibiotic?." Patient send an additional message on 3/27/2022 at 12:47pm "Sorry to keep adding messages, but want to update you on the latest. The red area on my arm was even larger when I woke up this morning (Sunday) so I went to an urgent care clinic. They determined it was cellulites, marked off the area and prescribed a 7 day dose of Cephalexin. They directed me to have a follow up visit with you tomorrow or Tuesday, and if I?m I?m unable to get in to see you , then to just come back and see them on Tuesday. I will call your office first thing tomorrow to see if a visit is possible, but I?m guessing you are all booked up." Patient was seen at Emergency Department on 3/25/22 and again on 3/27/2022. Patient was seen today, 3/30/2022 in follow-up. He is currently stable and improving.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- CBC x 2, Hepatic Function Panel, Lipase, Basic Metabolic panel, procalcitonin, lactate, chest xray
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma
- Andere Medikamente
- Vitamin D OTC supplement, Vitamin C OTC supplement, Albuterol 90mcg/puff PRN, montelukast 10mg qd, levocetirizine 5mg qd, guanfacine 1 mg qd
- Allergien
- Azelastine, fluticasone-salmeterol, penicillins, sulfa antibiotics, voriconazole
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 15.11.2023
- Impfdatum
- 21.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
No adverse event
Product administration error
Symptomtext
No known adverse reaction. This is more of an administration error. The patient received a Pnuemovax23 dose at another facility on 10-12-2020 per website. He was given another dose at pharmacy on 09-21-22, when based on age and history, the Prevnar13 was more appropriate to give if needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.05.2023
- Impfdatum
- 25.04.2023
- Beginn
- 25.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No symptomatic side effects; Inbound call from HCP stating that a patient was inadvertently administered PNEUMOVAX 23 past it's expiration date.; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. On 25-APR-2023, the patient was inadvertently vaccinated with expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) injection (formulation prefilled syringe, 0.5 mL, lot #U026796, expiration date 28-JAN-2023, route of administration and anatomical location were not provided) for prophylaxis (Expired vaccine used). No symptomatic side effects reported during time of a call. No additional adverse event (AE) details or product quality complaint (PQC).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.05.2023
- Impfdatum
- 24.04.2023
- Beginn
- 24.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AEs reported; expired dose of PNEUMOVAX 23 was administered; This spontaneous report was received from a pharmacist, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 24-APR-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe injection, at a dose of 0.5 milliliter, lot #U026796, expiration date: 28-JAN-2023, administered intramuscularly for prophylaxis (anatomical location was not provided) (expired product administered). No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 24.04.2023
- Impfdatum
- 23.03.2023
- Beginn
- 23.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional information or AE's reported; one expired dose of PNEUMOVAX 23 (syringes) was administered to a patient on 3/23/23 and vaccine expired on 1/28/23.; This spontaneous report was received from a nurse and referred to a 66-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 23-MAR-2023, the patient was vaccinated with one dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 ml injection, 1 quantity, lot #U026796, expiration date: 28-JAN-2023, administered intramuscularly for prophylaxis (expired product administered). There was no previous temperature excursion reported. No additional adverse event (AE) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.04.2023
- Impfdatum
- 08.03.2023
- Beginn
- 08.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No temp excursions and no symptomatic side effects reported by patient. No additional AE details or PQC; Inbound call from HCP stating that an expired PNEUMOVAX 23 was inadvertently administered past it's expiration date; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 08-MAR-2023, the patient was inadvertently vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe (dosage regimen, and route of administration were not provided), lot #U026796, expiration date: 28-JAN-2023, administered as prophylaxis (expired product administered). No temperature excursions and no symptomatic side effects were reported by patient (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 71,0
- Geschlecht
- U
- Eingang
- 10.03.2023
- Impfdatum
- 07.03.2023
- Beginn
- 07.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no additional AEs,; RN calling to report that expired lot of PNEUMOVAX 23 was administered on 3/7/2023 and requests information for revaccination recommendations. No further information provided, no additional AEs, no PQCs. LOT U026796 EXP 1/28/2023; This spontaneous report as received from a registered nurse concerning a 71-year-old patient, gender unspecified. There was no information about the patient's medical history, concurrent conditions or concomitant medication. On 07-MAR-2023 the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), prefilled syringe, dose: 0.5 milliliter, frequency reported as once (0.5ml/once), lot # U026796, expiration date: 28-JAN-2023 for prophylaxis (Expired product administered)(route unspecified). No further information provided, no additional adverse events, no PQCs.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.02.2023
- Impfdatum
- 22.02.2023
- Beginn
- 22.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
. No additional AE reported. No PQC report; Pharmacist reports administration of an expired dose of PNEUMOVAX 23 to a patient on 22FEB2023. Caller confirmed product was stored according to the recommended storage range until administered to the patient.; This spontaneous report has been received from pharmacist referring a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On 22-FEB-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), injection, lot number U026796 that had been verified to be a valid number with expiration date 28-JAN-2023, administered for prophylaxis (strength, specific dosage, vaccination scheme, route of administration and anatomical site of application were not provided) (expired product administered). Product was stored according to the recommended storage range until administered to the patient. No additional adverse event reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 24.02.2023
- Impfdatum
- 14.02.2023
- Beginn
- 14.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; Nurse reporting that a dose of PNEMOVAX23 with a labeled expiry of 1/28/2023 was inadvertently administered to a patient on 2/14/2023; This spontaneous report as received from a nurse and refers to a patient of unknown age and gender. No medical history, concurrent conditions nor concomitant medications were reported. On 14-FEB-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (0.5 mL, lot # U026796, expiration date 28-JAN-2023, route of administration and anatomical location were not provided) for prophylaxis (Expired vaccine used), inadvertent administration of vaccine beyond expiry date. It was reported no known temperature excursion involved. No additional information was provided. No additional adverse event (AE) or product quality complaint (PQC) was reported at the time of reporting.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.02.2023
- Impfdatum
- 16.02.2023
- Beginn
- 16.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AEs; Caller reported expired dose of PNEUMOVAX 23 was administered.; This spontaneous report has been received a medical assistant, regarding to patient of unknown age and gender. The patient's pertinent medical history, current conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 16-FEB-2023, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) (Expired product administered), injection, intramuscular (IM), at a dose of 0,5 milliliter (ml), administered for prophylaxis (lot number U026796 which was determined to be valid, with an expiration date on 28-JAN-2023) (strength and anatomical sites of injection were not provided). No adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.02.2023
- Impfdatum
- 01.02.2023
- Beginn
- 01.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
No other issues or concerns noted.; Nurse calling to report that a patient received an expired dose of PMEUMOVAX 23.; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, drug reaction or allergies, pertinent medical history and concomitant therapies were not reported. On 01-FEB-2023, the patient received an expired dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), lot # U026796, expiration date 28-JAN-2023, for prophylaxis (dose and route were not reported) (expired product administered). Nurse did not know if the product had a previous temperature excursion. No other issues or concerns noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 14.02.2023
- Impfdatum
- 08.02.2023
- Beginn
- 08.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE details were provided; patient was administered a dose of PNEUMOVAX 23 after it expired.; This spontaneous report was received from a nurse regarding a patient of an unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 08-FEB-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 milliliter, lot #U026796, expiration date: 28-JAN-2023 (strength, anatomical location, and route of administration were not provided) administered as prophylaxis (Expired product administered). No adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.02.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; she administered a dose of PNEUMOVAX 23 that was expired.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information of the patient's medical history, drug reaction/allergy, concurrent condition and concomitant therapy was not reported. On 30-JAN-2023, the patient was administrated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml (lot #U026796, expiration date: 28-JAN-2023, strength, anatomical location and route of administration were not provided) for prophylaxis (expired product administered). The product had not undergone any temperature excursions. No additional adverse event (AE).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 10.02.2023
- Impfdatum
- 08.02.2023
- Beginn
- 08.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; Healthcare provider reports administration of an expired dose of PNEUMOVAX 23 (prefilled syringe) to a patient on 2/8/2023.; This spontaneous report has been received from a medical assistant referring a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 08-FEB-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), injection, lot number U026796 with expiration date 28-JAN-2023, administered for prophylaxis (strength, specific dosage, vaccination scheme, route of administration and anatomical site of application were not provided) (expired product administered). The reporter confirmed product was not involved in a temperature excursion and has been stored within recommended storage range until date of administration. No additional adverse event or product quality complaints reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 07.02.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
Pt has not experienced and did not experience any signs or symptoms before. during, or after the vaccine was given. No treatment plan advised per Medical Director
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- M
- Eingang
- 02.02.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AEs; administration of expired lot of PNEUMOVAX 23 on 1/30/2023; This spontaneous report was received from a medical assistant referring to a 62-year-old male patient. Information of the patient's pertinent medical history, concomitant therapy, concurrent condition and drug reactions/allergies was not reported. On 30-JAN-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (0.5 milliliter, once, lot # U026796, expiration date upon internal review was established as 28-JAN-2023, strength and route of administration were not provided) for prophylaxis (expired product administered). No additional AEs (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 30.01.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Medication 2 days expired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Diabetes, Cancer
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- Basaglar, Metformin
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- M
- Eingang
- 30.01.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Expired vaccine given. Exp 1/28/23, given 1/30/23. No reaction
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 19.01.2023
- Impfdatum
- 17.01.2023
- Beginn
- 17.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
Pneumovax 23 given instead of Prevnar 13, no reactions. Dr. notified. Attempted to notify Parent x 4, voicemail not set up to receive messages. Spoke with relative, he stated he would give parent the message to call HD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 0,4
- Geschlecht
- F
- Eingang
- 19.01.2023
- Impfdatum
- 18.01.2023
- Beginn
- 18.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
Pneumovax 23 given instead of Prevnar 13, no reactions. Dr. notified. Parent notified, instructed on precaution and to bring patient back in 2weeks to receive Prevnar 13.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 29.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Patient was supposed to receive influenza vaccine and PREVNAR 20 (not Pneumovax), but MA accidentally gave Pneumovax because she did not check the orders first.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- hair loss, acne
- Vorgeschichte
- anxiety and depression tobacco abuse
- Andere Medikamente
- - Hydroxyzine PRN - Paxil - Ipratropium nasal - Magnesium oxide - Tretinoin topical
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 01.10.2022
- Impfdatum
- 15.09.2022
- Beginn
- 15.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Syringe issue
Underdose
Symptomtext
the patient received her first dose of PNEUMOVAX 23 on an unknown date in 2020; No other AE; the patient may not hace received full dose of PNEUNOMAX 23; The caller said the product leaked from the syringe; This spontaneous report has been received from a nurse and refers to a 67-year-old female patient. The patient's concurrent conditions included smoker. The patient's medical history, previous drug allergies or reactions, and concomitant therapies were not reported. On an unknown date in 2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, administered for prophylaxis (strength, lot number, expiry date, route of administration, and anatomical site of administration were not provided). On 15-SEP-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 1 dose, lot number u026796, expiration date reported as 28-JAN-2023, administered for prophylaxis (strength, route of administration, and anatomical site of administration were not provided); at the moment of the administration the product leaked from the syringe, and the patient may not have received the full dose of the vaccine (syringe issue, incorrect dose administered, inappropriate schedule of product administration). No other adverse event occurred.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Smoker
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 10.09.2022
- Impfdatum
- 10.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Product storage error
Symptomtext
No additional AE details; PNEUVMOAX 23 were administered after a supported temp excursion occurred.; 2 doses of PNEUVMOAX 23 were administered; This spontaneous report was received from a medical assistant and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 10-AUG-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (lot #U026796, expiration date: 28-JAN-2023; dose, strength and route of administration were unknown) for prophylaxis after a supported temperature excursion occurred (product storage error). The temperature was 9.2 C and time frame was 48 minutes. No previous temperature excursion. It was reported that the patient was vaccinated with 2 doses (extra dose administered) of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (lot #U026796, expiration date: 28-JAN-2023; dose, strength and route of administration were unknown) and the vaccination date of another dose was unknown. No additional adverse event (AE) details or product quality compliant (PQC).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 24.08.2022
- Impfdatum
- 10.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; PNEUVMOAX 23 were administered after a supported temp excursion occurred; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant medication were not provided. On 10-AUG-2022, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23), lot # U026796, expiration date 28-JAN-2023 for prophylaxis after a temperature excursion of 48 minutes at 9.2 degrees Celsius (Product storage error) (dose, route of administration, and injection anatomical location were not provided). No additional adverse events were reported (No adverse event). This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2208USA005566: US-009507513-2208USA005605:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Overdose
Product storage error
Symptomtext
No additional AE details or PQC.; 2 doses of PNEUVMOAX 23 were administered after a supported temp excursion occurred.; 2 doses of PNEUVMOAX 23 were administered after a supported temp excursion occurred.; This spontaneous report has been received from a medical assistant regarding a patient of unknown age and gender. The patient's concomitant medications, pertinent medical history, and drugs reactions/allergies were not reported. On 09-AUG-2022, 2 doses of Pneumococcal vaccine, polyvalent (23-valent) (PNEUVMOAX 23) injection (lot number: U026796, expiration date: 28-JAN-2023; strength, dose and route of administration were not provided) were administered for prophylaxis after a supported temperature excursion occurred (product storage error; overdose). The temperature excursion was of 9.2 Celsius degrees for 48 minutes. It was reported that there was no previous temperature exclusion. No additional adverse event (AE) details were reported. This is one of the three reports received from the same reporter. ; Sender's Comments: US-009507513-2208USA005566: US-009507513-2208USA005835:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 11.08.2022
- Impfdatum
- 10.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
Pneumo 23 given and should of been Prevnar 13. No adverse reaction. Per Pharmacist no harm to patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 70,0
- Geschlecht
- U
- Eingang
- 18.07.2022
- Impfdatum
- 10.06.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product confusion
Wrong product administered
Symptomtext
patient was asymptomatic. No additional AE reported.; accidentally administered PNEUMOVAX 23 instead of PREVNAR 20; product confusion; This spontaneous report was received from a clinical assistant referring to a 70-year-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 10-JUN-2022, the patient was accidentally administered pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (once, lot # U026796, expiration date: 28-JAN-2023; strength, dose, route of administration and anatomical location were not reported) for prophylaxis, instead of pneumococcal vaccine conj 20v (crm197) (PREVNAR 20) (strength, dose, route of administration, anatomical location, indication, lot# and expiration date were not reported) (wrong product administered and product confusion). Agent was filing an event due to product confusion. The patient was asymptomatic. No additional adverse event (AE) or product quality complaint (PQC) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 23.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 8,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
PPSV23 administered and guidelines recommended PCV20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 23.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
PPSV23 administered and guidelines were to administer PCV20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 23.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
PPSV23 administered rather than new guideline recommendation for PCV 20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- anxiety, osteopenia, osteoporosis
- Andere Medikamente
- fosamax, xanax, lipitor, miralax, vitamin d
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 13.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cough
Gait disturbance
Incoherent
Symptomtext
INCOHERENT- HAD TO BE HELPED TO WALK AROUND AND COUGHED ALL NIGHT. STARTED THAT EVENING AFTER VACCINATION. PT DID NOT TAKE ANY BENADRYL OR ANY OTHER. PT STATES IT LASTED FOR 2 DAYS. PT IS BETTER ON THURSDAY BETTER. PT IS REPORTING IT TODAY 5/13/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- CHF and CKD stage 3
- Andere Medikamente
- benzonatate (TESSALON) 100 MG capsule Take one capsule (100 mg total) by mouth 3 (three) times a day as needed for cough. diazePAM (VALIUM) 5 MG tablet Take one tablet (5 mg total) by mouth every 6 (six) hours as needed for anxiety or other
- Allergien
- morphine and statins
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.05.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Syringe issue
Symptomtext
Issues with some PNEUMOVAX23 having a broken flange; no adverse event; This spontaneous report was received from an office manager. The reporter stated there were issues with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe (lot number U026796, which was verified to be a valid lot number, expiration date reported and upon internal validation established as 28-JAN-2023). The flange was broken (syringe issue). No adverse events were reported. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2111USA008646: US-009507513-2111USA009249: US-009507513-2204USA007667: US-009507513-2204USA007829:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; nurse calling to report a temperature excursion for PNEUMOVAX 23; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 28-FEB-2022, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot number U026796, expiration date 28-JAN-2023 (dose and route of administration not reported) as prophylaxis, underwent a temperature excursion of 48.8 Fahrenheit for 96 hours. No adverse event was reported. No previous temperature excursions were reported. This is one of 4 cases received from the same reporter. ; Sender's Comments: US-009507513-2203USA002142: US-009507513-2203USA002143: US-009507513-2203USA000257:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; nurse calling to report a temperature excursion for PNEUMOVAX 23; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 28-FEB-2022, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot number U026796, expiration date 28-JAN-2023 (dose and route of administration not reported) as prophylaxis, underwent a temperature excursion of 48.8 Fahrenheit for 96 hours. No adverse event was reported. No previous temperature excursions were reported. This is one of 4 cases received from the same reporter. ; Sender's Comments: US-009507513-2203USA002142: US-009507513-2203USA000257: US-009507513-2203USA002144:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; nurse calling to report a temperature excursion for PNEUMOVAX 23; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 28-FEB-2022, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot number U026796, expiration date 28-JAN-2023 (dose and route of administration not reported) as prophylaxis, which had undergone a temperature excursion of 48.8 Fahrenheit for 96 hours. No adverse event was reported. No previous temperature excursions were reported. This is one of 4 cases received by the same reporter. ; Sender's Comments: US-009507513-2203USA000257: US-009507513-2203USA002143: US-009507513-2203USA002144:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -